Close Menu

In the UK, GSK and the Medical Research Council have joined forces to make the most of larger GWAS data sets, reports the UK's Business Weekly. In order to maximize the statistical potential of genome-wide association studies, the two will combine data sets and invest £1 million each over three years to focus on finding the genetic switches for two main diseases, depression and obesity.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.